FABP4 and obesity disorder: A-FABP is also identified as the mediator of obesity-related complications such as steatohepatitis27 and atherosclerosis26 by inducing inflammatory activity, inhibiting cholesterol efflux or mediating lipid-induced ER stress in macrophages28, 29.